Christopher T. Rhodes

1.1k total citations
39 papers, 797 citations indexed

About

Christopher T. Rhodes is a scholar working on Molecular Biology, Developmental Neuroscience and Pharmaceutical Science. According to data from OpenAlex, Christopher T. Rhodes has authored 39 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Developmental Neuroscience and 6 papers in Pharmaceutical Science. Recurrent topics in Christopher T. Rhodes's work include Epigenetics and DNA Methylation (7 papers), Neurogenesis and neuroplasticity mechanisms (7 papers) and Drug Solubulity and Delivery Systems (6 papers). Christopher T. Rhodes is often cited by papers focused on Epigenetics and DNA Methylation (7 papers), Neurogenesis and neuroplasticity mechanisms (7 papers) and Drug Solubulity and Delivery Systems (6 papers). Christopher T. Rhodes collaborates with scholars based in United States, United Kingdom and Switzerland. Christopher T. Rhodes's co-authors include Sriram Vemuri, Michele Danish, Arati Deshpande, John W. Frankenfeld, George C. Fuller, Mitchel S. Berger, Timothy J. Petros, Yufeng Wang, Peter A. Schwartz and Richard Sandstrom and has published in prestigious journals such as Nature Communications, Neuron and Scientific Reports.

In The Last Decade

Christopher T. Rhodes

37 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher T. Rhodes United States 13 350 198 164 105 68 39 797
R. J. Mumper United States 13 384 1.1× 219 1.1× 358 2.2× 218 2.1× 72 1.1× 13 1.3k
Lucia Bondioli Italy 13 313 0.9× 155 0.8× 300 1.8× 155 1.5× 24 0.4× 17 698
Libero Italo Giannola Italy 18 234 0.7× 540 2.7× 83 0.5× 73 0.7× 82 1.2× 61 1.2k
Iftikhar Khan United Kingdom 20 572 1.6× 456 2.3× 141 0.9× 84 0.8× 128 1.9× 74 1.3k
A Fundarò Italy 10 481 1.4× 538 2.7× 296 1.8× 95 0.9× 76 1.1× 24 926
Gopal Venkatesh Shavi India 16 195 0.6× 329 1.7× 255 1.6× 118 1.1× 31 0.5× 21 680
David C. Bibby United Kingdom 11 224 0.6× 288 1.5× 232 1.4× 121 1.2× 36 0.5× 26 775
Jacques‐Emile Proust France 8 376 1.1× 320 1.6× 236 1.4× 95 0.9× 99 1.5× 9 797
Ngoc Trinh Huynh Vietnam 14 383 1.1× 191 1.0× 424 2.6× 254 2.4× 73 1.1× 24 1.0k
Jiahorng Liaw Taiwan 19 384 1.1× 284 1.4× 201 1.2× 72 0.7× 18 0.3× 29 823

Countries citing papers authored by Christopher T. Rhodes

Since Specialization
Citations

This map shows the geographic impact of Christopher T. Rhodes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher T. Rhodes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher T. Rhodes more than expected).

Fields of papers citing papers by Christopher T. Rhodes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher T. Rhodes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher T. Rhodes. The network helps show where Christopher T. Rhodes may publish in the future.

Co-authorship network of co-authors of Christopher T. Rhodes

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher T. Rhodes. A scholar is included among the top collaborators of Christopher T. Rhodes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher T. Rhodes. Christopher T. Rhodes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rhodes, Christopher T., Mira Sohn, Shovan Naskar, et al.. (2024). Loss of Ezh2 in the medial ganglionic eminence alters interneuron fate, cell morphology and gene expression profiles. Frontiers in Cellular Neuroscience. 18. 1334244–1334244.
2.
Zhang, Yajun, et al.. (2022). Generation of single-cell and single-nuclei suspensions from embryonic and adult mouse brains. STAR Protocols. 4(1). 101944–101944. 3 indexed citations
3.
Rhodes, Christopher T., Joyce J. Thompson, Apratim Mitra, et al.. (2022). An epigenome atlas of neural progenitors within the embryonic mouse forebrain. Nature Communications. 13(1). 4196–4196. 18 indexed citations
4.
Mahadevan, Vivek, Apratim Mitra, Yajun Zhang, et al.. (2021). NMDARs Drive the Expression of Neuropsychiatric Disorder Risk Genes Within GABAergic Interneuron Subtypes in the Juvenile Brain. Frontiers in Molecular Neuroscience. 14. 712609–712609. 9 indexed citations
5.
Wester, Jason C., Vivek Mahadevan, Christopher T. Rhodes, et al.. (2019). Neocortical Projection Neurons Instruct Inhibitory Interneuron Circuit Development in a Lineage-Dependent Manner. Neuron. 102(5). 960–975.e6. 46 indexed citations
6.
Rhodes, Christopher T., Giulia Zunino, Sandra M. Cardona, et al.. (2018). Region specific knock-out reveals distinct roles of chromatin modifiers in adult neurogenic niches. Cell Cycle. 17(3). 377–389. 9 indexed citations
7.
Rhodes, Christopher T., et al.. (2017). Comparative analyses identify molecular signature of MRI-classified SVZ-associated glioblastoma. Cell Cycle. 16(8). 765–775. 16 indexed citations
8.
Rhodes, Christopher T., et al.. (2016). Cross-species analyses unravel the complexity of H3K27me3 and H4K20me3 in the context of neural stem progenitor cells. PubMed. 6. 10–25. 15 indexed citations
9.
Sandstrom, Richard, Eric Haugen, Christopher T. Rhodes, et al.. (2014). Epigenetic Regulation by Chromatin Activation Mark H3K4me3 in Primate Progenitor Cells within Adult Neurogenic Niche. Scientific Reports. 4(1). 5371–5371. 20 indexed citations
10.
Sandstrom, Richard, et al.. (2014). Molecular targets of chromatin repressive mark H3K9me3 in primate progenitor cells within adult neurogenic niches. Frontiers in Genetics. 5. 252–252. 14 indexed citations
11.
Rhodes, Christopher T., et al.. (2010). Regulatory compliance requirements for an open source electronic image trial management system. PubMed. 2010. 3475–3478. 3 indexed citations
12.
Vemuri, Sriram & Christopher T. Rhodes. (1995). Preparation and characterization of liposomes as therapeutic delivery systems: a review. Pharmaceutica Acta Helvetiae. 70(2). 95–111. 402 indexed citations
13.
Romero, Alain, et al.. (1991). An evaluation of ibuprofen bioinversion by simulation. Chirality. 3(5). 418–421. 7 indexed citations
14.
Dabbah, Roger, et al.. (1987). Scientific and Regulatory Aspects of Macromolecular Drugs and Devices. Drug Development and Industrial Pharmacy. 13(4-5). 873–968. 4 indexed citations
15.
Rhodes, Christopher T., et al.. (1987). Glidants and Lubricant Properties of Several Types of Talcs. Drug Development and Industrial Pharmacy. 13(13). 2441–2467. 16 indexed citations
16.
Schwartz, Peter A., Christopher T. Rhodes, & Douglas S. Greene. (1981). Effect of Free Fatty Acid Concentration on Furosemide Binding to Human Serum Albumin. Pharmacology. 22(6). 364–370. 12 indexed citations
17.
Schwartz, Peter A., Douglas S. Greene, & Christopher T. Rhodes. (1980). Effect of sodium oleate on salicylic acid binding to human serum albumin. Journal of Pharmaceutical Sciences. 69(11). 1345–1348. 5 indexed citations
18.
Birmingham, Bruce K., Douglas S. Greene, & Christopher T. Rhodes. (1979). Percutaneous Absorption of Salicylic Acid in Rabbits. Drug Development and Industrial Pharmacy. 5(1). 29–40. 2 indexed citations
19.
Fuller, George C., et al.. (1978). Potential of liquid membranes for drug overdose treatment: In vitro studies. Journal of Pharmaceutical Sciences. 67(1). 63–66. 39 indexed citations
20.
Blunden, Gerald & Christopher T. Rhodes. (1968). Stability of Diosgenin. Journal of Pharmaceutical Sciences. 57(4). 602–604. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026